Abstract
The present decade should witness significant advances in the understanding and control of varicella-zoster (V-Z) infection. In vitro assays for examining the many aspects of the host’s immune responses have recently been developed, and immunotherapy including zoster immune globulin (ZIG), hyperimmune plasma, varicella-zoster vaccine, and transfer factor are now being examined for therapeutic efficacy. Previous attempted modes of treatment such as antiviral chemotherapeutic agents have generally been inadequate, yet preliminary results indicate that various aspects of immunotherapy may provide the clinical armamentarium so long awaited for combating this ubiquitous viral agent. An understanding of the immunology of V-Z virus disease is of course essential for guiding efforts at therapy and such investigations are currently developing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong, R. W., and Merigan, T. C., 1971, Varicella zoster virus; interferon production and comparative interferon sensitivity in human cell cultures, J. Gen. Virol. 12:53–54.
Asano, Y., Yazaki, T., Miyata, T., Nakayama, H., and Hirose, S., 1975, Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection, Biken J. 18(l):35–40.
Asano, Y., Yazaki, T., Ito, S., Isomura, S., and Takahashi, M., 1976, Letter: Contact infection from live varicella vaccine recipients. Lancet 1(7966):965.
Asano, Y., Nakayama, H., Yazaki, T., Kato, R., Hirose, S., Tsuzuki, K., Ito, S., Isumura, S., and Takashashi, M., 1977a, Protection against varicella family contacts by immediate inoculation with live varicella vaccine. Pediatrics 59:3–7.
Asano, Y., Nakayama, H., Yazaki, T., Ito, S., Isomura, S., and Takashashi, M., 1977b, Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics 59:8–12.
Betts, R. F., Azky, D. A., Douglas, R. W., Jr., and Royer, G., 1975, Ineffectiveness of subcutaneous cytosine arabinoside in locaHzed herpes zoster, Ann. Intern. Med. 82(6):788–783.
Boda, D., 1975, Letter: Immunization against varicella (the priority of P:AL Fernoz), Orv. Hetil. 116(47):2807.
Brunell, P. A., 1966, Placental transfer of varicella-zoster antibody.Pediatrics 38:1034–1038.
Brunell, P. A., 1975, Vaccination against herpesviruses. Pediatrics 56(4):496–498.
Brunell, P. A., 1977, Protection against varicella. Pediatrics 59:1–2.
Brunell, P. A., and Casey, H. L., 1964, A crude tissue culture antigen for the protection of varicella-zoster complement fixing antibody. Public Health Rep. 79:839–842.
Brunell, P. A., and Gershon, A., 1973, Passive immunization against varicella-zoster infections and other modes of therapy. Rev. J. Infect. Dis. 127:412–423.
Brunell, P. A., Ross, A., Miller, L. H., and Kuo, B., 1969, Prevention of varicella by zoster immune globulin, N. Eng. J. Med. 280:1191–1194.
Brunell, P. A., Gershon, A. A., Uduman, S. A., and Steinberg, S., 1975, Varicella-zoster immunoglobulins during varicella, latency, and zoster, J. Infect. Dis. 132(l):499–54.
Ch’in, L. T., Whitley, R. G., and Alford, A. A., Jr., 1975, The NIAID sponsored cooperative anti-viral clinical study, central unit: Adenine arabinoside (ARA-A) and herpex zoster (V-Z) in the immunosuppressed—A crossover control study, 15 th Inter sci. Conf. Antimi- crob. Agents Chemother., Abstr. 360.
Drew, W. L., Blume, M. R., Miner, R., Silverberg, J., and Rosenbaum, E. H., 1973, Herpes zoster: Transfer factor therapy, Ann. Intern. Med. 79:747–748.
Feldman, S., and Epp, E., 1976, Isolation of varicella-zoster virus from blood, J. Pediatr. 88:265–267.
Feldman, S., Hughes, W. T., and Danie, C. B., 1975, Varicella in children with cancer: Seventy-seven cases. Pediatrics 56:388–397.
Felsenfeld, A. D., and Schmidt, N. J., 1975, Immunological relationship between delta herpesvirus of patas monkeys and varicella-zoster virus of humans, Infect. Immun. 12(2):261–266.
Fischer, G. W., Podgore, J. K., Bass, J. W., Kelley, J. L., and Kobayashi, G. W., 1975, Enhanced host defense mechanisms with levamisole in suckling rats, J. Infect. Dis. 132:578–581.
Frey, H. M., Bialkin, G., and Gershon, A. A., 1977, Congenital varicella: Case report of a serologically proved long term survivor.Pediatrics 59:110–112.
Geiser, C. F., Bishop, Y., Myers, M., Jaffe, N., and Yankee, R., 1975, Prophylaxis of varicella in children with neoplastic disease: Comparative results with zoster immune plasma and gamma globulin, Cancer 35(4):1027–1030.
Gershon, A. A., 1975, Varicella in mother and infant: Problems old and new, in: Infections of the Fetus and Newborn Infant (S. Krugman and A. A. Gershon, eds.), pp. 79–95, Alan R. Liss, New York.
Gershon, A. A., and Krugman, S., 1975, Seroepidemiol- ogic survey of varicella: Value of specific fluorescent antibody test. Pediatrics 56:1005–1008.
Gershon, A. A., Kalter, Z. G., Steinberg, S., and Kuhns, W. T., 1976a, Detection of antibody to varicella-zoster virus by immune adherence hemagglutination, Proc. Soc. Exp. Biol. Med. 151(4):762–765.
Gershon, A. A., Raker, R., Steinberg, S., Topf-Olstein, B., and Drusin, L. M., 1976b, Antibody to varicella- zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692–696.
Gershon, A. A., Steinberg, S., and Smith, M., 1976c, Cell- mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes. Infect. Immun. 13(6): 1549–1553.
Gold, E., 1966, Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection, N. Eng. J. Med. 274:181–185.
Heuschele, W. P., 1960, Varicella (chickenpox) in three young anthropoid apes, J. Am. Vet. Med. Assoc. 136:256–257.
Hope-Simpson, R. E., 1965, The nature of herpes zoster: A long-term study and a new hypothesis, Proc. R. Soc. Med. 58:9–20.
Jordan, G. W., and Merigan, T. C., 1975, Cell-mediated immunity to varicella zoster virus: in vitro lymphocyte responses, J. Infect. Dis. 130(5):495–501.
Kamiya, H., 1977, Diagnostic skin test reactions with varicella virus antigen and clinical application of the test, J. Infect. Dis. 136:784–788.
Kundratitz, K., 1925, Experimentelle Ăœbertragungen von Herpes zoster auf den Menschen und die Beziehunger von Herpes zoster zu Varicellen, Monats sehr. Kinderh. 29:516–521.
Leonard, L. L., Schmidt, N. J., and Lenette, E. H., 1970, Demonstration of viral antibody activity in two immunoglobulin G subclasses in patients with varicella-zoster virus infection, J. Immunol. 104:23–27.
Marcy, S. M., and Kibrick, S., 1972, Varicella and herpes zoster, in: Infectious Diseases (P. D. Hoeprich, ed.), pp. 825–829, Harper and Row, Hagerstown, Md.
Moe, F. J., 1974, Letter: Prevention against varicella and herpes zoster in individuals with impaired immunological defense, Tidsskr. Nor Laegeforen 94(34–36):2409.
Neumann-Haefelin, D., Sundmacher, R., Sauter, B., Karges, H. E., and Manthey, K. F., 1975, Effect of human leukocyte interferon on vaccinia and herpes virus infected cell cultures and monkey corneas. Infect. Immun. 12(1):148–155.
Ono, Y., Takahashi, C., Miyoshi, K., Ideguchi, S., and Sesaki, M., 1975, Seroepidemiological study of varicella-zoster virus by complement fixation reaction, J. Jpn. Assoc. Infect. Dis. 49(1): 18–24.
Orfanos, C. E., and Runne, W., 1975, Virus propagation, virus replication and virus elimination in the human skin in zoster, Hautarzt 26(4):181–190.
Plotkin, S. A., 1975, Vaccination against herpes group viruses. Pediatrics 56(4):494–496.
Rifkind, D., 1966, The activiation of varicella-zoster infections by immunosuppressive therapy, J. Lab. Clin. Med. 68:463–474.
Ruckdeschel, J. O., and Mardiney, M. R., Jr., 1976, The demonstration of cell-associated immunity to viruses: In vitro lymphocyte responsiveness to varicella-zoster antigen, J. Immunol. Methods 13:(2): 131–143.
Russell, A. S., Maini, R. A., Bailey, M., and Dumode, D. C., 1972, Cell-mediated immunity to varicella-zoster antigen and acute herpes zoster (shingles), Clin. Exp. Immunol. 14:181–185.
Schmidt, N. J., and Lennette, E. H., 1975, Neutralizing antibody responses to varicella-zoster virus. Infect. Immun. 12(3):606–613.
Seip, M., and Lie, S. O., 1975, Letter: Varicella prevention in persons with impaired immunoapparatus, Tidsskr. Nor Laegeforen 94(28): 1934–1935.
Shibuta, H., Ishikawa, T., Hondo, R., Royama, Y., Kurata, K., and Motumoto, M., 1974, Varicella virus isolation from spinal ganglion. Arch. Gesamte Virusforsch. 45(4):382–385.
Smith, K. O., Gehle, W. D., and Sanford, B. A., 1974, Evidence for chronic viral infections in human arteries, Proc. Soc. Exp. Biol. Med. 147(2):375–360.
Snipes, W., Person, S., Keller, G., Taylor, W., and Keith, A., 1977, Inactivation of lipid-containing viruses by long-chain alcohols, Antimicrol. Agents Chemother. 11:98–104.
Steele, R. W., 1980, Transfer factor and cellular reactivity to varicella-zoster antigen in childhood leukemia. Cell. Immunol 50:282–289.
Steele, R. W., Hensen, S. A., Vincent, M. M., Fuccillo, D. A., and Bellanti, J. A., 1973, A51 Cr microassay technique for cell-mediated immunity to viruses, J. Immunol 110:1502–1510.
Steele, R. W., Chapa, I. A., Vincent, M. M., Hensen, S. A., and Keeney, R. E., 1975, Effects of adenine arabinoside on cellular immune mechanisms in humans, Antimicrob. Agents Chemother. 7:203–207.
Steele, R. W., Keeney, R. W., Brown, J., III, and Young, E. J., 1977, Cellular immune responses to herpes group viruses during treatment with adenine arabinoside, J. Infect. Dis. 135:593–599.
Steele, R. W., Vincent, M. M., and Berry, D. H., 1980, Passive transfer of skin test reactivity to varicella-zoster antigen in childhood leukemia and prevention of disease with transfer factor, in: Current Chemotherapy and Infectious Disease, p. 1438, The American Society for Microbiology, Washington, D.C.
Stevens, D. A., and Merigan, T. C., 1972, Interferon, antibody, and other host factors in herpes zoster, J. Clin. Invest. 41:1170–1178.
Stevens, D. A., Ferrington, R. A., Jordan, G. W., and Merigan, T. C., 1975, Cellular events in zoster vesicles: Relation to cHnical course and immune parameters, J. Infect. Dis. 131(5):509–515.
Strabstein, J. C., Morris, N., Larke, R. P. B., et al., 1974, Is there a congenital varicella syndrome, J. Pediatr. 84:239.
Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., and Yazaki, T., 1974, Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2(7892):1288–1290.
Takahashi, M., Okuno, Y., Otsuka, T., Isame, J., and Takamizawa, A., 1975, Development of a live attenuated varicella vaccine, Biken J. 18(l):25–33.
Triebwasser, J. H., Harris, R. E., Bryant, R. E., and Rhoades, E. T., 1967, Varicella pneumonia in adults: Report of seven cases and a review of literature. Medicine 46:409–423.
Trlifajov, A. J., Ryba, M., and Jelinek, J., 1976, Indirect haemagglutination reaction (LH) the method of choice for the detection of anamnestic antibodies to varicella- zoster (UZ) virus, J. Hyg. Epidemiol. Microbiol. Immunol. 20(1): 101–106.
Tyzzer, E. E., 1906, Varicella-zoster, Philipp. J. Sci. 1:349–353.
Uduman, S. A., Gershon, A. A., and Brunell, P. A., 1972, Rapid diagnosis of varicella-zoster infection by agar-gel diffusion, J. Infect. Dis. 126:193–195.
Uduman, S. A., Gershon, A. A., and Brunell, P. A., 1975, Should patients with zoster receive zoster immune globulin, J. Am. Med. Assoc. 234(1): 1049–1051.
Von Bokay, J., 1909, Ueber den ätiologischen Zusammenhang der Varizellen mit gewissen Fallen von Herpes zoster, Wien. Klin. Wochenschr. 22:1323–1329.
Whitley, R. J., Alford, C. A., Jr., and Chin, L. T., 1975, The NIAID sponsored cooperative anti-viral clinical study, central unit: Factors influencing the response of immuno-suppressed persons with herpes-zoster (V-Z) to adenine arabinoside (Ara-A) therapy, 15th Intersci. Conf. Antimicrob. Agents Chemother., Abstr. 359.
Wildy, P., 1973, Herpes: History and classification, in: The Herpes Virus (A. S. Kaplan, ed.) p. 19, Academic Press, New York.
Williams, v., Gershon, A., and Brunell, P. A., 1974, Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence, J. Infect. Dis. 130(6):669–672.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Steele, R.W. (1982). Immunology of Varicella-Zoster Virus. In: Nahmias, A.J., O’Reilly, R.J. (eds) Immunology of Human Infection. Comprehensive Immunology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1012-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1012-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1014-3
Online ISBN: 978-1-4684-1012-9
eBook Packages: Springer Book Archive